Protecting Pregnant Women From Infectious Diseases

The primary research aim of this project is to test the effectiveness of a comprehensive,
evidence-based vaccine promotion package implemented in the obstetric setting on increasing
the likelihood that a pregnant woman in Georgia will receive an influenza vaccine and/or
Tdap vaccine before delivery. A secondary research aim assesses whether the comprehensive
package improves maternal knowledge, attitudes, and beliefs regarding maternal and infant
vaccination. The intervention package will include evidence-based components aimed at the
practice-level, provider-level, and patient level and will be tested through a
cluster-randomized trial design. The primary outcome measure is influenza vaccine receipt
during pregnancy. The secondary outcomes include 1) receipt of pertussis (Tdap) vaccination
during pregnancy, and 2) changes in maternal knowledge, attitudes and beliefs regarding
maternal and infant vaccination. The primary hypothesis is that implementation of a
comprehensive vaccine promotion package in the obstetric setting will increase the
likelihood that a pregnant woman receives an influenza and/or pertussis vaccination.

Inclusion Criteria:

- Between the ages of 18 - 50

- Currently pregnant

- Unvaccinated with 2012 - 2013 seasonal influenza vaccine

- Unvaccinated with Tdap vaccine during current pregnancy

Exclusion Criteria:

- Under 18 years of age or over 50

- Not currently pregnant

- Previous receipt of 2012 - 2013 seasonal influenza vaccine

- Previous receipt of Tdap vaccine during current pregnancy

- Does not speak English